NeoGenomics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price
NeoGenomics, Inc. (NEO) had Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price of $5.66 per share as of 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice · last filed 2023-05-09
- 2023-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $5.66.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $6.42.
- 2022-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $6.51.
- 2022-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $6.70.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price |
|---|---|
| 2023-03-31 | $5.66 10-Q · filed 2023-05-09 |
| 2022-12-31 | $6.42 10-K · filed 2023-02-24 |
| 2022-09-30 | $6.51 10-Q · filed 2022-11-08 |
| 2022-06-30 | $6.70 10-Q · filed 2022-08-09 |
| 2022-03-31 | $9.98 10-Q · filed 2022-05-09 |
| 2021-12-31 | $18.87 10-K · filed 2023-02-24 |
| 2021-09-30 | $18.19 10-Q · filed 2021-11-04 |
| 2021-06-30 | $18.53 10-Q · filed 2021-08-09 |
| 2021-03-31 | $19.42 10-Q · filed 2021-05-06 |
| 2020-12-31 | $8.88 10-K · filed 2023-02-24 |
| 2020-09-30 | $8.88 10-Q · filed 2020-10-29 |
| 2020-06-30 | $8.81 10-Q · filed 2020-07-31 |
| 2020-03-31 | $8.90 10-Q · filed 2020-04-29 |
| 2019-12-31 | $5.77 10-K · filed 2022-02-25 |
| 2019-09-30 | $5.76 10-Q · filed 2019-11-13 |
| 2019-06-30 | $6.05 10-Q · filed 2019-08-07 |
| 2019-03-31 | $5.64 10-Q · filed 2019-05-08 |
| 2018-12-31 | $2.80 10-K · filed 2021-02-25 |
| 2018-09-30 | $2.63 10-Q · filed 2018-11-06 |
| 2018-06-30 | $2.61 10-Q · filed 2018-08-06 |
| 2018-03-31 | $2.78 10-Q · filed 2018-05-08 |
| 2017-12-31 | $2.26 10-K · filed 2020-02-28 |
| 2017-09-30 | $2.24 10-Q · filed 2017-11-13 |
| 2017-06-30 | $2.23 10-Q · filed 2017-08-07 |
| 2017-03-31 | $2.86 10-Q · filed 2017-05-09 |
| 2016-12-31 | $2.23 10-K · filed 2019-02-26 |
| 2016-09-30 | $2.56 10-Q · filed 2016-11-07 |
| 2016-06-30 | $2.57 10-Q · filed 2016-08-05 |
| 2015-12-31 | $1.84 10-K · filed 2018-03-13 |
| 2014-12-31 | $1.50 10-K · filed 2017-03-14 |
| 2013-12-31 | $1.19 10-K · filed 2016-04-18 |
| 2012-12-31 | $0.73 10-K · filed 2015-03-03 |
| 2011-12-31 | $0.51 10-K · filed 2014-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |